Skip to main content

Lapse in Appropriations

Please note that a lapse in appropriations has caused GAO to shut down its operations. Therefore, GAO will not be able to publish reports or otherwise update this website until GAO resumes operations. In addition, the vast majority of GAO personnel are not permitted to work. Consequently, calls or emails to agency personnel may not be returned until GAO resumes operations. For details on how the bid protest process will be handled during the shutdown, please see the legal decisions page. For information related to the GAO Personnel Appeals Board (PAB), please see the PAB webpage.

Health Insurance: Coverage of Autologous Bone Marrow Transplantation for Breast Cancer

HEHS-96-83 Published: Apr 24, 1996. Publicly Released: May 28, 1996.
Jump To:

Highlights

Pursuant to a congressional request, GAO reviewed insurance coverage of autologous bone marrow transplantation (ABMT) for breast cancer, focusing on: (1) the factors insurers consider when deciding whether to cover treatment; (2) the effectiveness of the treatment; and (3) the consequences of the increased use and insurance coverage of the treatment while it is still in clinical trials.

Full Report

Full Report (29 pages)

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs
media@gao.gov

Public Inquiries

Contact Us

Topics

Health Care
Breast cancerCancer researchChemotherapyHealth care cost controlHealth care servicesHealth insuranceHealth insurance cost controlHealth research programsMedicaidMedical services ratesMedicareRadiation exposure hazardsWomenOrgan and tissue transplantation